rs148909799
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_002454.3(MTRR):āc.1982A>Gā(p.His661Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0031 in 1,614,224 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_002454.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MTRR | NM_002454.3 | c.1982A>G | p.His661Arg | missense_variant | 15/15 | ENST00000440940.7 | NP_002445.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MTRR | ENST00000440940.7 | c.1982A>G | p.His661Arg | missense_variant | 15/15 | 1 | NM_002454.3 | ENSP00000402510 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00192 AC: 293AN: 152242Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.00187 AC: 471AN: 251296Hom.: 2 AF XY: 0.00194 AC XY: 264AN XY: 135822
GnomAD4 exome AF: 0.00323 AC: 4719AN: 1461864Hom.: 9 Cov.: 31 AF XY: 0.00320 AC XY: 2330AN XY: 727232
GnomAD4 genome AF: 0.00192 AC: 293AN: 152360Hom.: 1 Cov.: 32 AF XY: 0.00168 AC XY: 125AN XY: 74506
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:2
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Jun 15, 2017 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 25, 2018 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Feb 25, 2021 | The MTRR c.1982A>G; p.His661Arg variant (rs148909799), to our knowledge, is not reported in the medical literature or gene specific databases. This variant is reported as uncertain significance/likely benign in ClinVar (Variation ID: 203841), and is found in the general population with an overall allele frequency of 0.19% (523/277,022 alleles, including 2 homozygotes) in the Genome Aggregation Database. The histidine at codon 661 is weakly conserved, and computational analyses (SIFT, PolyPhen-2) predict that this variant is tolerated. Computational analyses (Alamut v.2.11) predict that this variant may impact splicing by creating a novel cryptic acceptor splice site, however without mRNA analysis it is unclear if this variant impacts splicing. Due to limited information, the clinical significance of the p.His661Arg variant is uncertain at this time. - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2022 | MTRR: BP4 - |
Disorders of Intracellular Cobalamin Metabolism Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. - |
Methylcobalamin deficiency type cblE Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
MTRR-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 06, 2023 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at